Is Early Cessation of Chemoradiotherapy Preventing Access to Adjuvant Immunotherapy for Patients with Stage III NSCLC?

M. P. MacManus,M. Alexander, J. Xie,D. Ball,B. Solomon, N. Plumridge,M. Shaw, S. Harden,F. Hegi-Johnson,S. Siva,T. John, A. Officer, N. Wallace

Journal of Thoracic Oncology(2023)

引用 0|浏览0
暂无评分
关键词
chemoradiotherapy,immunotherapy,comorbidity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要